Cargando…

Delivery Systems for the Direct Application of siRNAs to Induce RNA Interference (RNAi) In Vivo

RNA interference (RNAi) is a powerful method for specific gene silencing which may also lead to promising novel therapeutic strategies. It is mediated through small interfering RNAs (siRNAs) which sequence-specifically trigger the cleavage and subsequent degradation of their target mRNA. One critica...

Descripción completa

Detalles Bibliográficos
Autor principal:	Aigner, Achim
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559929/ https://www.ncbi.nlm.nih.gov/pubmed/17057369 http://dx.doi.org/10.1155/JBB/2006/71659

Ejemplares similares

Applications of RNA interference: current state and prospects for siRNA-based strategies in vivo
por: Aigner, Achim
Publicado: (2007)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

RNAi therapeutics: Can siRNAs conquer SARS?
por: Chang, Z, et al.
Publicado: (2005)

RNAiAtlas: a database for RNAi (siRNA) libraries and their specificity
por: Mazur, Sławek, et al.
Publicado: (2012)

Designer siRNAs to overcome the challenges from the RNAi pathway
por: Jayasena, Sumedha D
Publicado: (2005)

Therapeutic siRNA: State-of-the-Art and Future Perspectives
por: Friedrich, Maik, et al.
Publicado: (2022)

siRNAs Induce Efficient RNAi Response in Bombyx mori Embryos
por: Yamaguchi, Junichi, et al.
Publicado: (2011)

Novel siRNA Delivery System to Target Podocytes In Vivo
por: Hauser, Peter V., et al.
Publicado: (2010)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Polymeric Nanoparticles Based on Tyrosine-Modified, Low Molecular Weight Polyethylenimines for siRNA Delivery
por: Ewe, Alexander, et al.
Publicado: (2019)

Oral Delivery of Double-Stranded RNAs and siRNAs Induces RNAi Effects in the Potato/Tomato Psyllid, Bactericerca cockerelli
por: Wuriyanghan, Hada, et al.
Publicado: (2011)

Asymmetrically designed siRNAs and shRNAs enhance the strand specificity and efficacy in RNAi
por: Ding, Hongliu, et al.
Publicado: (2007)

Minimizing off-target effects by using diced siRNAs for RNA interference
por: Myers, Jason W, et al.
Publicado: (2006)

RNA interference by mixtures of siRNAs prepared using custom oligonucleotide arrays
por: Oleinikov, Andrew V., et al.
Publicado: (2005)

Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs
por: Koehn, Sandra, et al.
Publicado: (2010)

Essential Notes Regarding the Design of Functional siRNAs for Efficient Mammalian RNAi
por: Ui-Tei, Kumiko, et al.
Publicado: (2006)

Multiplexing siRNAs to compress RNAi-based screen size in human cells
por: Martin, Scott E., et al.
Publicado: (2007)

A RNA nanotechnology platform for a simultaneous two-in-one siRNA delivery and its application in synergistic RNAi therapy
por: Jang, Mihue, et al.
Publicado: (2016)

Generation of siRNA Nanosheets for Efficient RNA Interference
por: Kim, Hyejin, et al.
Publicado: (2016)

Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc–siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5′-exonuclease
por: Kumar, Pawan, et al.
Publicado: (2020)

Utilizing Selected Di- and Trinucleotides of siRNA to Predict RNAi Activity
por: Han, Ye, et al.
Publicado: (2017)

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
por: Davis, Mark E., et al.
Publicado: (2010)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Mosquito and Drosophila entomobirnaviruses suppress dsRNA- and siRNA-induced RNAi
por: van Cleef, Koen W.R., et al.
Publicado: (2014)

RNAi mechanisms in Huntington’s disease therapy: siRNA versus shRNA
por: Aguiar, Sebastian, et al.
Publicado: (2017)

Profiling of mismatch discrimination in RNAi enabled rational design of allele-specific siRNAs
por: Huang, Huang, et al.
Publicado: (2009)

Optimal choice of functional and off-target effect-reduced siRNAs for RNAi therapeutics
por: Ui-Tei, Kumiko
Publicado: (2013)

Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs
por: Agarwal, Saket, et al.
Publicado: (2021)

Non-viral siRNA delivery into the mouse retina in vivo
por: Turchinovich, Andrey, et al.
Publicado: (2010)

Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo Delivery
por: Tai, Wanyi
Publicado: (2019)

MicroRNAs that interfere with RNAi
por: Massirer, Katlin B., et al.
Publicado: (2013)

Progress towards in Vivo Use of siRNAs
por: Behlke, Mark A.
Publicado: (2006)

Engineering RNA for Targeted siRNA Delivery and Medical Application()
por: Guo, Peixuan, et al.
Publicado: (2010)

Medical applications of RNA interference (RNAi)
por: Pereira, Tiago Campos, et al.
Publicado: (2013)

siRNA-Finder (si-Fi) Software for RNAi-Target Design and Off-Target Prediction
por: Lück, Stefanie, et al.
Publicado: (2019)

siRNA Specificity: RNAi Mechanisms and Strategies to Reduce Off-Target Effects
por: Neumeier, Julia, et al.
Publicado: (2021)

Forward and robust selection of the most potent and noncellular toxic siRNAs from RNAi libraries
por: Li, Zhen, et al.
Publicado: (2009)

siRNA Mediate RNA Interference Concordant with Early On-Target Transient Transcriptional Interference
por: Fang, Zhiming, et al.
Publicado: (2021)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_pq902kljp0g704agur79r1l46f